https://www.selleckchem.com/pr....oducts/taurocholic-a
The levels of IGF-1 and ROS are abnormally elevated in various tumor tissues, and IGF-1 has been reported to be associated with the development and progression of inflammation in cancers. In this study, we found that IGF-1 activated NF-κB and NLRP3 inflammatory signaling via IRS-1/mPGES-1/NOX2-regulated ROS. Additionally, in the B16-F10 tumor-bearing mouse model, the number of tumors, tumor growth, invasion of tissues, and expression of proinflammatory factors in peripheral blood were significantly decreased